Kenvue shares jump as activist investor Starboard buys in.

Shares in American consumer health products group Kenvue were surging on Monday morning on reports that activist investor Starboard Value has amassed a "sizeable stake" in the company.

Kenvue Inc
21 October 2024 14:50:17

Source: Sharecast

According to the Wall Street Journal, Starboard wants to boost the share price of Kenvue, which has underperformed the wider sector since the start of 2024.

The report, citing people familiar with the matter, suggested Starboard would push Kenvue's management to "make changes", but did not specify what the investment firm had in mind.

The size of the stake was not disclosed, but Starboard chief executive Jeff Smith is expected to appear at the 13D Monitor Active-Passive Investor Summit in New York on Tuesday and could unveil details there, the WSJ reported.

Tylenol and Aveeno maker Kenvue, the former consumer healthcare arm of Johnson & Johnson that was spun out in 2023, was trading 6.4% higher at $23.11 by 0944 ET.

As of Friday's closing price of $21.72, the stock had barely changed since the start of the year, compared with a 23% gain on the S&P 500.

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

View our accounts

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.